Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,100
Closed -$46K 986
2019
Q1
$46K Hold
1,100
﹤0.01% 895
2018
Q4
$34K Hold
1,100
﹤0.01% 805
2018
Q3
$48K Buy
+1,100
New +$31.2K 0.01% 873
2018
Q1
Sell
-1,200
Closed -$16K 821
2017
Q4
$16K Buy
+1,200
New +$22.8K ﹤0.01% 845
2017
Q3
Sell
-2,200
Closed -$45K 838
2017
Q2
$45K Buy
2,200
+700
+47% +$15.5K 0.01% 806
2017
Q1
$35K Sell
1,500
-988
-40% -$21.7K ﹤0.01% 817
2016
Q4
$45K Buy
2,488
+414
+20% +$8.93K 0.01% 783
2016
Q3
$58K Buy
2,074
+761
+58% +$21.3K 0.01% 785
2016
Q2
$33K Buy
+1,313
New +$48K 0.01% 752

Other funds holding AFMD

Wedbush Securities's AFMD Position: Q2 2019 in Review

Wedbush Securities sold out of Affimed (AFMD) in Q2 2019, closing a stake of 1,100 shares — an estimated $46K sold.

Wedbush Securities first reported a position in AFMD in Q2 2016 and held it in 9 quarters. The position peaked at $58K in Q3 2016. 83 funds tracked by Wall St. Rank hold AFMD as of Q2 2019.

  • Wedbush Securities reported no remaining Affimed position as of Q2 2019 after selling out during the quarter.
  • Wedbush Securities sold 1,100 Affimed shares in Q2 2019, an estimated $46K.
  • Wedbush Securities first reported a position in Affimed in Q2 2016 and held it in 9 quarters.
  • Wedbush Securities's Affimed position peaked at $58K in Q3 2016.
  • 83 funds tracked by Wall St. Rank held Affimed as of Q2 2019.

Based on Wedbush Securities's 13F filing for Q2 2019, filed 1 Aug 2019.